CLOV vs XLO · rev $1.37B vs rev $19.1M
Clover Health Investments Corp (CLOV) versus Xilio Development Inc (XLO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Xilio Development Inc (XLO) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported XLO revenue for 2025-09-30 was $19.1M. Net income was -$45.4M. XLO currently screens at market cap $55.3M.
CLOV currently screens at market cap $1.55B. XLO currently screens at market cap $55.3M.
Not investment advice. Open the CLOV and XLO stock pages for the full models.
Not investment advice.